Kuros Biosciences Raises 2026 Annual Guidance After Nine-Month Sales Rise 40%
Kuros Biosciences reported a 40% year-over-year increase in sales for the first nine months of 2026 and increased its annual guidance.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Kuros Biosciences reported a 40% year-over-year increase in sales for the first nine months of 2026 and increased its annual guidance.